Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing–remitting multiple sclerosis

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

(2010) Daniel Wynn et al.   LANCET NEUROLOGY

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

(2010) Gavin Giovannoni et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis

(2009) Massimiliano Calabrese et al.   ARCHIVES OF NEUROLOGY

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

(2009) G Comi et al.   LANCET

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

(2009) Paul O'Connor et al.   LANCET NEUROLOGY

Magnetic resonance evidence of cortical onset of multiple sclerosis

(2009) M Calabrese et al.   Multiple Sclerosis Journal

Accumulation of cortical lesions in MS: relation with cognitive impairment

(2009) SD Roosendaal et al.   Multiple Sclerosis Journal

Brain atrophy as an outcome measure for multiple sclerosis clinical trials: A "no-brainer"?

(2009) R. A. Rudick et al.   NEUROLOGY

Cortical lesions in primary progressive multiple sclerosis: A 2-year longitudinal MR study

(2009) M. Calabrese et al.   NEUROLOGY

Extensive cortical inflammation is associated with epilepsy in multiple sclerosis

(2008) M. Calabrese et al.   JOURNAL OF NEUROLOGY

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

(2008) Daniel D Mikol et al.   LANCET NEUROLOGY

Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study

(2008) M Calabrese et al.   Multiple Sclerosis Journal